Alpha-synuclein and oxidative stress enzymes as biomarkers of Parkinson’s disease
- 1 April 2017
- journal article
- Published by Pleiades Publishing Ltd in Neurochemical Journal
- Vol. 11 (2) , 121-128
Abstract
The principal mechanism of the pathogenesis of Parkinson’s disease is accumulation and aggregation of alpha-synuclein. While the normal function of alpha-synuclein is the control of vesicular neurotransmission, its pathogenic effects influence different cell functions, including the activities of mitochondria and proteasomes, as well as autophagic protein degradation. It is noteworthy that the same functions are affected when the renewal of macromolecules and organelles is impaired as a result of normal aging. Since aging is the principal risk factor for Parkinson’s disease, it is very important to analyze its molecular and cellular consequences in the context of alpha-synuclein pathology. Here, we review the similarities and differences between normal brain aging and Parkinson’s disease, with a focus on nigral dopaminergic neurons, which seem to be specifically sensitive to the combined damage induced by alpha-synuclein and aging. Elucidating the mechanism that underlies the death of dopaminergic neurons in Parkinson’s disease is essential not only for the understanding of its general pathogenesis but also for the development of approaches to its early preclinical diagnosis and preventive therapy.Keywords
This publication has 54 references indexed in Scilit:
- Cardiovascular dysautonomia in Parkinson disease: From pathophysiology to pathogenesisNeurobiology of Disease, 2012
- Plasma epidermal growth factor levels predict cognitive decline in Parkinson diseaseAnnals of Neurology, 2010
- αβγ-Synuclein triple knockout mice reveal age-dependent neuronal dysfunctionProceedings of the National Academy of Sciences, 2010
- Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after EndocytosisNeuron, 2010
- Interplay between Cytosolic Dopamine, Calcium, and α-Synuclein Causes Selective Death of Substantia Nigra NeuronsNeuron, 2009
- Olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disordersActa Neuropathologica, 2008
- Iron in Chronic Brain Disorders: Imaging and Neurotherapeutic ImplicationsNeurotherapeutics, 2007
- α-synuclein locus duplication as a cause of familial Parkinson's diseaseThe Lancet, 2004
- The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementiaAnnals of Neurology, 2003
- AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITYBrain, 1991